Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07376148

Fractional CO2 Laser-assisted Delivery of Hyaluronic Acid, Ascorbic Acid and Sodium DNA For Enhancing Facial Skin Quality in Individuals Over the Age of 30

Status
Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Instituto de Oftalmología Fundación Conde de Valenciana · Academic / Other
Sex
All
Age
30 Years
Healthy volunteers
Not accepted

Summary

Evaluate the effectiveness of topical hyaluronic acid, ascorbic acid, and sodium DNA following ablative fractional laser treatment in objectively reversing facial skin alterations induced by photoaging.

Detailed description

The study involves the application of ascorbic acid, hyaluronic acid, and sodium DNA in preparation for their use following the administration of a fractional CO2 laser treatment. Participants will attend a total of four sessions. During the initial session, participants will complete and sign a consent form, baseline photographs will be captured for documentation purposes, and an initial assessment will be conducted using the SASSQ. At the second session, the fractional CO2 laser will be applied, followed by the application of the topical medication to the facial area. During the third and fourth sessions, scheduled one week and four weeks post-treatment, respectively, the facial dermal effects will be objectively evaluated using the SASSQ scale, and any adverse effects will be assessed and documented through photographs. To facilitate the analysis and comparison of variables, an analysis of variance will be conducted utilizing the ANOVA test for repeated measures. The IBM SPSS Statistics software, version 29.0, will be employed for this purpose. A p-value of less than 0.05 will be regarded as statistically significant.

Conditions

Interventions

TypeNameDescription
DRUGtopical hyaluronic acid, ascorbic acid, and sodium DNA following ablative fractional laser treatmentThe study involves the application of ascorbic acid, hyaluronic acid, and sodium DNA in preparation for their use following the administration of a fractional CO2 laser treatment

Timeline

Start date
2025-11-07
Primary completion
2026-02-28
Completion
2026-04-30
First posted
2026-01-29
Last updated
2026-01-29

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT07376148. Inclusion in this directory is not an endorsement.